# Sunshine Biopharma Inc.: Form 8-K, filed Nov 2, 2023

- Company: [Sunshine Biopharma Inc.](/companies/sbfm.md) (CIK 1402328)
- Form: 8-K
- Filed: 2023-11-02
- Accepted by EDGAR: Nov 2, 2023, 12:18 ET
- Period: 2023-11-02
- Accession: 0001683168-23-007582
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1402328/000168316823007582/sunshine_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1402328/000168316823007582/

## Items reported

- Item 1.02: Termination of a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1402328/000168316823007582/sunshine_8k.htm

Filed Nov 2, 2023.
Source: SEC EDGAR, the filing index for accession 0001683168-23-007582. Last ingested by Listed: Nov 11, 2026, 03:50 ET. No prices; not investment advice.